Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies
Shohei Watanabe,
Kazuki Yoshizumi,
Sayaka Moriguchi,
Tomoki Higashiyama,
Yoshiki Negi,
Koji Mikami,
Takashi Kimura
Affiliations
Shohei Watanabe
Department of Neurology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan; Corresponding author at: Department of Neurology, Hyogo College of Medicine, 1-1, Mukogawa-Cho, Nishinomiya, Hyogo 663-8501, Japan.
Kazuki Yoshizumi
Department of Neurology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
Sayaka Moriguchi
Department of Neurology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
Tomoki Higashiyama
Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
Yoshiki Negi
Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
Koji Mikami
Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
Takashi Kimura
Department of Neurology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
